JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duysen, E. G.
Right arrow Articles by Lockridge, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duysen, E. G.
Right arrow Articles by Lockridge, O.

Vol. 299, Issue 2, 528-535, November 2001

Evidence for Nonacetylcholinesterase Targets of Organophosphorus Nerve Agent: Supersensitivity of Acetylcholinesterase Knockout Mouse to VX Lethality

Ellen G. Duysen, Bin Li , Weihua Xie , Lawrence M. Schopfer, Robert S. Anderson, Clarence A. Broomfield and Oksana Lockridge

Eppley Institute, University of Nebraska Medical Center, Omaha, Nebraska (E.G.D., B.L., W.X., L.M.S., O.L.); Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska (B.L., W.X., O.L.); and U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Aberdeen, Maryland (R.S.A., C.A.B.)

The possibility that organophosphate toxicity is due to inhibition of targets other than acetylcholinesterase (AChE, EC 3.1.1.7) was examined in AChE knockout mice. Mice (34-55 days old) were grouped for this study, after it was determined that AChE, butyrylcholinesterase (BChE), and carboxylesterase activities had reached stable values by this age. Mice with 0, 50, or 100% AChE activity were treated subcutaneously with the nerve agent VX. The LD50 for VX was 10 to 12 µg/kg in AChE-/-, 17 µg/kg in AChE+/-, and 24 µg/kg in AChE+/+ mice. The same cholinergic signs of toxicity were present in AChE-/- mice as in wild-type mice, even though AChE-/- mice have no AChE whose inhibition could lead to cholinergic signs. Wild-type mice, but not AChE-/- mice, were protected by pretreatment with atropine. Tissues were extracted from VX-treated and untreated animals and tested for AChE, BChE, and acylpeptide hydrolase activity. VX treatment inhibited 50% of the AChE activity in brain and muscle of AChE+/+ and +/- mice, 50% of the BChE activity in all three AChE genotypes, but did not significantly inhibit acylpeptide hydrolase activity. It was concluded that the toxicity of VX must be attributed to inhibition of nonacetylcholinesterase targets in the AChE-/- mouse. Organophosphorus ester toxicity in wild-type mice is probably due to inhibition or binding to several proteins, only one of which is AChE.


0022-3565/01/2992-0528$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by U.S. Government



This article has been cited by other articles:


Home page
J EndocrinolHome page
C. De Vriese and C. Delporte
Autocrine proliferative effect of ghrelin on leukemic HL-60 and THP-1 cells
J. Endocrinol., January 1, 2007; 192(1): 199 - 205.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
G. B. Quistad, R. Klintenberg, and J. E. Casida
Blood Acylpeptide Hydrolase Activity Is a Sensitive Marker for Exposure to Some Organophosphate Toxicants
Toxicol. Sci., August 1, 2005; 86(2): 291 - 299.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. De Vriese, F. Gregoire, P. De Neef, P. Robberecht, and C. Delporte
Ghrelin Is Produced by the Human Erythroleukemic HEL Cell Line and Involved in an Autocrine Pathway Leading to Cell Proliferation
Endocrinology, March 1, 2005; 146(3): 1514 - 1522.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. De Vriese, F. Gregoire, R. Lema-Kisoka, M. Waelbroeck, P. Robberecht, and C. Delporte
Ghrelin Degradation by Serum and Tissue Homogenates: Identification of the Cleavage Sites
Endocrinology, November 1, 2004; 145(11): 4997 - 5005.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. G. Duysen, C. F. Bartels, and O. Lockridge
Wild-Type and A328W Mutant Human Butyrylcholinesterase Tetramers Expressed in Chinese Hamster Ovary Cells Have a 16-Hour Half-Life in the Circulation and Protect Mice from Cocaine Toxicity
J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 751 - 758.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.